Trials / Unknown
UnknownNCT06268561
Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
OZURDEX endophthalmitis is a rare and potentially very serious pathology. Different treatments can be carried out early and change the functional prognosis of the patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Visual acuity analysis | Collection of information on visual acuity from the medical file concerning the surgery |
| OTHER | Intraocular pressure analysis | Collection of information on intraocular pressure from the medical file concerning the surgery |
| OTHER | Analysis of optical coherence tomography (OCT) images | Collection and analysis of optical coherence tomography (OCT) images of the medical file concerning the surgery |
| OTHER | Analysis of retinograms | Collection and analysis of retinography images of the medical file concerning the surgery |
Timeline
- Start date
- 2023-06-05
- Primary completion
- 2024-06-01
- Completion
- 2024-06-01
- First posted
- 2024-02-20
- Last updated
- 2024-02-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06268561. Inclusion in this directory is not an endorsement.